Literature DB >> 9120950

Antiandrogen withdrawal syndrome with nilutamide.

L G Gomella1, M Ismail, F E Nathan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9120950

Source DB:  PubMed          Journal:  J Urol        ISSN： 0022-5347            Impact factor:   7.450


× No keyword cloud information.
  6 in total

1.  Antiandrogen withdrawal in castrate-refractory prostate cancer: a Southwest Oncology Group trial (SWOG 9426).

Authors:  A Oliver Sartor; Catherine M Tangen; Maha H A Hussain; Mario A Eisenberger; Minoti Parab; Joseph A Fontana; Robert A Chapman; Glenn M Mills; Derek Raghavan; E David Crawford
Journal:  Cancer       Date:  2008-06       Impact factor: 6.860

2.  Identification of a new androgen receptor (AR) co-regulator BUD31 and related peptides to suppress wild-type and mutated AR-mediated prostate cancer growth via peptide screening and X-ray structure analysis.

Authors:  Cheng-Lung Hsu; Jai-Shin Liu; Po-Long Wu; Hong-Hsiang Guan; Yuh-Ling Chen; An-Chi Lin; Huei-Ju Ting; See-Tong Pang; Shauh-Der Yeh; Wen-Lung Ma; Chung-Jung Chen; Wen-Guey Wu; Chawnshang Chang
Journal:  Mol Oncol       Date:  2014-06-24       Impact factor: 6.603

Review 3.  Secondary hormonal manipulation of prostate cancer.

Authors:  K A Harris; E J Small
Journal:  Curr Urol Rep       Date:  2001-06       Impact factor: 3.092

Review 4.  Novel agents in the management of castration resistant prostate cancer.

Authors:  Shruti Chaturvedi; Jorge A Garcia
Journal:  J Carcinog       Date:  2014-03-05

Review 5.  Enzalutamide and blocking androgen receptor in advanced prostate cancer: lessons learnt from the history of drug development of antiandrogens.

Authors:  Yusuke Ito; Marianne D Sadar
Journal:  Res Rep Urol       Date:  2018-02-16

6.  A dramatic, objective antiandrogen withdrawal response: case report and review of the literature.

Authors:  Yiu-Keung Lau; Manpreet K Chadha; Alan Litwin; Donald L Trump
Journal:  J Hematol Oncol       Date:  2008-11-05       Impact factor: 17.388
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.